Al Gharaibeh, Faris N.
Lahni, Patrick
Alder, Matthew N.
Wong, Hector R.
Article History
Received: 21 April 2022
Revised: 17 November 2022
Accepted: 22 November 2022
First Online: 13 December 2022
Competing interests
: Cincinnati Children’s Research foundation and Hector Wong hold U.S. patents for the PERSEVERE biomarkers. Cincinnati Children’s Research foundation and F.N.A. have filed for a U.S. patent for nPERSEVERE.
: This study was reviewed by the institutional review board at Cincinnati Children’s Hospital Medical Center and the University of Cincinnati and consent was waived.